Phuturdex › Diseases › Myocardial ischemia
Drugs in development · updated 30 October 2026
Myocardial ischemia: drugs in development
As of 30 October 2026 there are 5 active clinical trials (recruiting or ongoing, phases I–III) on 6 drugs for myocardial ischemia. 0 are experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| IvabradineCorlanor®, Ivabradine Anpharm® | II–III | 2 | NCT07268170 |
| AtenololTenormin® | II–III | 1 | NCT07268170 |
| MetoprololLopressor®, Kapspargo Sprinkle® | II–III | 1 | NCT07268170 |
| ColchicineColchicin, Lodoco® | II | 1 | NCT05472337 |
| RegadenosonLexiscan, Rapiscan® | I–II | 1 | NCT04604782 |
| DapagliflozinForxiga, Dapagliflozin Propanediol | I | 1 | NCT05762952 |
Sorted by most advanced phase and number of active trials.
All 6 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Coronary artery disease 34 drugs
- Myocardial infarction 26 drugs
- Myocardial infarction with ST segment elevation 22 drugs
- Acute coronary syndrome 17 drugs
- Atherosclerosis 34 drugs
- Cardiogenic shock 13 drugs
- Cardiovascular disease 71 drugs
- Inflammation 85 drugs
- Stroke 70 drugs
- Microvascular angina 7 drugs
- Heart failure 104 drugs
- Peripheral Arterial Disease 25 drugs
Broader categories
- Vascular disease 16 drugs
- Heart disease 17 drugs
- Cardiovascular disease 71 drugs
- Ischemia 5 drugs
- Necrosis 9 drugs
- Coronary Disease 3 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D017202 “Myocardial Ischemia”.